![](https://www.diabetesnews.com/wp-content/uploads/2012/12/Eye_iris-150x150.jpg)
The device, created by Dr. Isaac Lipshitz, CEO of OptoLight Vision Technology in Israel, restores vision lost through end-stage age-related macular degeneration. The U.S. Food and Drug Administration (FDA) recently revised its criteria regarding which patients can use this treatment